Literature DB >> 22886962

Establishment of reproducible xenotransplantation model of T cell acute lymphoblastic leukemia in NOD/SCID mice.

Di Wang1, Na Wang1, Yan Zhang2, Shuyan Ma2, Zhe Geng1, Pengfei Zhou2, Jianfeng Zhou1, Liang Huang1.   

Abstract

T cell acute lymphoblastic leukemia (T-ALL) is an aggressive leukemia. However the poor prognosis and low morbidity restrict further analysis of the disease. Therefore there is an increasing demand to develop animal models for identifying novel therapeutic approaches. In this study, we inoculated the anti-mouse CD122 monoclonal antibody conditioned NOD/SCID mice with the leukemia cells from 9 T-ALL patients and 1 cell line via the tail vein. Four of the 9 patients and the cell line were successfully engrafted. Flow cytometry detected high percentage of human CD45(+) cells in recipient mice. Immunohistochemistry showed infiltration of human CD45(+) cells in different organs. Serial transplantation was also achieved. In vivo drug treatment showed that dexamethasone could extend survival, which was consistent with clinical observation. These results demonstrated that we successfully established 5 xenotransplantation models of T-ALL in anti-mCD122 mAb conditioned NOD/SCID mice, which recapitulated the characteristics of original disease.

Entities:  

Mesh:

Year:  2012        PMID: 22886962     DOI: 10.1007/s11596-012-0088-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  31 in total

1.  Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.

Authors:  C Lavau; R T Luo; C Du; M J Thirman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 2.  Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis.

Authors:  T Lapidot; Y Fajerman; O Kollet
Journal:  J Mol Med (Berl)       Date:  1997-09       Impact factor: 4.599

3.  An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.

Authors:  P D Aplan; C A Jones; D S Chervinsky; X Zhao; M Ellsworth; C Wu; E A McGuire; K W Gross
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

4.  High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.

Authors:  J C Wang; T Lapidot; J D Cashman; M Doedens; L Addy; D R Sutherland; R Nayar; P Laraya; M Minden; A Keating; A C Eaves; C J Eaves; J E Dick
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

5.  Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.

Authors:  L E Ailles; B Gerhard; H Kawagoe; D E Hogge
Journal:  Blood       Date:  1999-09-01       Impact factor: 22.113

6.  Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells.

Authors:  Joby L McKenzie; Olga I Gan; Monica Doedens; John E Dick
Journal:  Blood       Date:  2005-05-05       Impact factor: 22.113

7.  Human AML cells in NOD/SCID mice: engraftment potential and gene expression.

Authors:  R Lumkul; N-C Gorin; M T Malehorn; G T Hoehn; R Zheng; B Baldwin; D Small; S Gore; D Smith; P S Meltzer; C I Civin
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

8.  Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.

Authors:  Cristina G de Guzman; Alan J Warren; Zheng Zhang; Larry Gartland; Paul Erickson; Harry Drabkin; Scott W Hiebert; Christopher A Klug
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells.

Authors:  T Tanaka; M Tsudo; H Karasuyama; F Kitamura; T Kono; M Hatakeyama; T Taniguchi; M Miyasaka
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

10.  AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.

Authors:  Daniel J Pearce; David Taussig; Kazem Zibara; Lan-Lan Smith; Christopher M Ridler; Claude Preudhomme; Bryan D Young; Ama Z Rohatiner; T Andrew Lister; Dominique Bonnet
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

View more
  1 in total

1.  SIL-TAL1 rearrangement is related with poor outcome: a study from a Chinese institution.

Authors:  Di Wang; Guangrong Zhu; Na Wang; Xiaoxi Zhou; Yunfan Yang; Shiqiu Zhou; Jie Xiong; Jing He; Lijun Jiang; Chunrui Li; Danmei Xu; Liang Huang; Jianfeng Zhou
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.